Guardant Health, Inc. (GH) vs Mettler-Toledo International, Inc. (MTD)
- Guardant Health, Inc. GH 158.29 −4.58%
- Mettler-Toledo International, Inc. MTD 1,622.29 −1.02%
Guardant Health, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $32.8B against $22.3B — 1.5× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Mettler-Toledo International, Inc. trades at 36.4×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs −38.3%) and the higher return on invested capital (35.4% vs −129.7%). Across the 18 metrics below, Mettler-Toledo International, Inc. leads on 10 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | GH | MTD | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 60.26% | 50.89% |
| Operating margin | (39.75%) | 28.41% | (8.57%) |
| Net margin | (38.33%) | 21.91% | (6.37%) |
| Free cash flow margin | (20.35%) | 20.90% | 0.00% |
| Return on equity | 171.64% | (736.36%) | (2.92%) |
| Return on assets | (27.95%) | 25.61% | (6.71%) |
| Return on invested capital | (129.70%) | 35.40% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack